2 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 04700849 2024-04-01 2025-03-31 04700849 2025-03-31 04700849 2024-03-31 04700849 2023-04-01 2024-03-31 04700849 2024-03-31 04700849 2023-03-31 04700849 bus:Director2 2024-04-01 2025-03-31 04700849 core:WithinOneYear 2025-03-31 04700849 core:WithinOneYear 2024-03-31 04700849 bus:Director1 2024-04-01 2025-03-31 04700849 bus:Micro-entities 2024-04-01 2025-03-31 04700849 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 04700849 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 04700849 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 04700849 bus:FullAccounts 2024-04-01 2025-03-31
COMPANY REGISTRATION NUMBER: 04700849
Synergy Medical Limited
Filleted Unaudited Financial Statements
31 March 2025
Synergy Medical Limited
Financial Statements
Year ended 31 March 2025
Contents
Pages
Balance sheet and the notes to the financial statements
1 to 2
Synergy Medical Limited
Balance Sheet
31 March 2025
2025
2024
£
£
Fixed assets
1,199,327
1,139,840
------------
------------
Current assets
914,446
607,916
Creditors: amounts falling due within one year
218,738
156,480
------------
------------
Net current assets
695,708
451,436
------------
------------
Total assets less current liabilities
1,895,035
1,591,276
Accruals and deferred income
4,740
4,518
------------
------------
1,890,295
1,586,758
------------
------------
Capital and reserves
1,890,295
1,586,758
------------
------------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2024: 3 ).
2. Basis of preparation
The financial statements have been prepared on the historical cost basis.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Monetary amounts in these financial statements are rounded to the nearest £.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 12 December 2025 , and are signed on behalf of the board by:
Ms J M Silveira
Director
Company registration number: 04700849
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Park House The Bridle Path, Seabridge, Newcastle under Lyme, ST5 3SH